±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 11-09 À¯ÀÏÇÑ È¦ 14:10~14:40 New treatment guideline review ÇÑÅ¿µ(À»ÁöÀÇ´ë) ±³À°½Ã°£ 11-09 À¯ÀÏÇÑ È¦ 14:40~15:10 Update on topical agents in AD treatment °íÇöâ(ºÎ»êÀÇ´ë) ±³À°½Ã°£ 11-09 À¯ÀÏÇÑ È¦ 15:10~15:40 The link between skin barrier and immune dysregulation in AD and topical treatment for acute flare Kenshi Yamasaki(Tohoku university) ±³À°½Ã°£ 11-09 À¯ÀÏÇÑ È¦ 16:00~16:30 The role of IL-4 and IL-13 in pathogenesis ÀÌÁöÇö(Ä«Å縯ÀÇ´ë) ±³À°½Ã°£ 11-09 À¯ÀÏÇÑ È¦ 16:30~17:00 Clinical practice of novel targeted agent Dupilumab in adult AD treatment Ken Igawa(Tokyo university) ±³À°½Ã°£ 11-09 À¯ÀÏÇÑ È¦ 17:00~17:30 The potential new target and approach Àå¿ëÇö(°æºÏÀÇ´ë)